Takahashi K, Wang F, Morita K, Yan Y, Patel K, Bueso-Ramos CE, Gumbs C, Zhang J, Kornblau S, DiNardo CD, Ravandi F, Garcia-Manero G, Jabbour EJ, Andreeff M , Kantarjian HM, Konopleva M, Futreal A
But there had been suggestions from previous work that such cells also make GLP-1, a more widely known hormone of the gut
For anti-diabetic GLP-1s, Medicares policy and Commercial payers reluctance to offer widespread coverage of AOMs leads to a bolus of comorbid patients in both channels attempting to initiate anti-diabetic GLP-1 therapy for their weight-loss advantages
In COPD, CS disrupts peroxisomal function, reducing catalase activity and increasing PUFAs (111)
Rodgers, P
Tolliver, B.K., Anton, R.F